We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Jan. 17, 2025 – Medicare will negotiate the prices of weight loss drugs Wegovy and Ozempic with drug companies, a move that could create big savings for seniors who take the drugs, the Biden ...

She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.

The Biden administration unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. It kicks off the second phase of a landmark ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...

If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...